Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ferrol
Clinical trial register · Spain

Clinical Trials in Ferrol, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company11 AbbVie8 Novo Nordisk A/S4 Janssen Research & Development, LLC4 Hoffmann-La Roche3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Ferrol

58 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Eli Lilly and Company
Phase 3
2,001
Alcobendas, Barcelona, Centelles, Ferrol, Granada, Madrid, Pozuelo de Alarcón, Seville
2026-08-26
Recruiting
AstraZeneca
Phase 3
1,500
A Coruña, Alzira, Barcelona, Ferrol, Lleida, Málaga, Oviedo, Segovia
2026-08-20
Recruiting
Novo Nordisk A/S
Phase 3
450
Fuenlabrada, Almería, Castilleja de la Cuesta, Ferrol, Madrid, Santiago de Compostela, Seville
2026-08-12
Recruiting
AstraZeneca
Phase 3
900
Barcelona, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Seville
2026-07-06
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Alicante, Barcelona, Ferrol, Gijón, Girona, Madrid, Navarra, Santiago de Compostela
2026-04-21
Recruiting
Novo Nordisk A/S
Phase 3
400
A Coruña, Badalona, Ferrol, Madrid, Málaga, San Sebastián de Los Reyes (Madrid), Santander, Santiago de Compostela
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 3
400
A Coruña, Badalona, Ferrol, Madrid, Málaga, San Sebastián de Los Reyes (Madrid), Santander, Santiago de Compostela
2026-04-13
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Badalona, A Coruña, Ferrol, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Seville
2026-03-23
Recruiting
Eli Lilly and Company
Phase 3
900
A Coruña, Almería, Barcelona, Ferrol, Palma de Mallorca, Pozuelo de Alarcón, Santander, Seville
2026-02-10
Active, closed
Kailera
Phase 3
1,270
Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia
2026-01-12
Recruiting
Norgine
Phase 3
212
Ferrol, Palma de Mallorca, Sabadell, Madrid, Málaga
2025-12-29
Active, closed
Kailera
Phase 3
2,530
Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia
2025-12-18
Recruiting
Takeda
Phase 3
70
Ferrol, Madrid, Seville, Valencia
2025-10-27
Recruiting
Eli Lilly and Company
Phase 3
4,500
A Coruña, Badalona, Barcelona, Ferrol, Huelva, Madrid, Palma, Pontevedra
2025-10-15
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Barcelona, Ferrol, Galdakao, Gijón, Girona, Madrid, Santiago de Compostela, Seville
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
220
A Coruña, Barcelona, Cadiz, Castellon, Ferrol, Jerez de la Frontera, Madrid, Málaga
2025-09-10
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
A Coruña, Barcelona, Centelles, Córdoba, Ferrol, Granada, Huelva, Jaén
2025-09-02
Active, closed
Hoffmann-La Roche
Phase 2
330
Seville, Santander, Castilleja de la Cuesta, A Coruña, Ferrol, Malaga, Málaga, Barcelona
2025-08-19
Recruiting
Eli Lilly and Company
Phase 3
290
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
2025-06-26
Recruiting
GlaxoSmithKline
Phase 3
981
Pozuelo de Alarcón, Marbella, Alzira, Barcelona, Benalmádena, Ferrol, GaldakaoVizcaya, Madrid
2025-06-20
Recruiting
Intraligamentary vs Inferior Alveolar Nerve Block for Pulpitis: A Randomized Clinical Trial
NCT07130760Symptomatic Irreversible Pulpitis (SIP), Dental Pain, Inferior Alveolar Nerve Block Failure, Local Anesthesia
Aula Dental Avanzada
Not applicable
52
Ferrol, Alicante
2025-06-20
By invitation
Novo Nordisk A/S
Observational
1,250
Barcelona, Cartagena, Castilleja de la Cuesta, El Palmar (Murcia), Ferrol, Getafe (Madrid), La Cuesta (Santa Cruz de Tenerife), Las Palmas de Gran Canaria
2025-05-01
Active, closed
Eli Lilly and Company
Phase 3
905
A Coruña, Barcelona, Ferrol, Móstoles, Santander, Seville
2025-04-25
Recruiting
Persei Vivarium
Not applicable
196
Ferrol, Palma de Mallorca
2025-04-15
Not yet open
Universidad de Oviedo
Observational
212
Ferrol
2025-03-10
Recruiting
Takeda
Phase 3
70
Ferrol, Madrid, Seville, Valencia
2025-01-22
Recruiting
Fundación GECP
Observational
50
Ferrol, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Girona, A Coruña
2024-10-03
Recruiting
Sacituzumab govitEcan in THYroid Cancers
NCT06235216Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer
DrugSacituzumab Govitecan
Grupo Espanol de Tumores Neuroendocrinos
Phase 2
42
Barcelona, Ferrol, Hospitalet de Llobregat (Barcelona), Madrid, Murcia, Oviedo, Santander, Zaragoza
2024-09-13
Recruiting
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
NCT06782217Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
DrugVenox
Inmunotek S.L.
Observational
120
Ferrol, Plasencia, Burela de Cabo, Monforte de Lemos, A Coruña, Barcelona, Lugo, Ourense
2024-09-01
Recruiting
AbbVie
Phase 3
110
Ferrol, Esplugues de Llobregat, Málaga, Seville, Zaragoza
2024-08-08
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ferrol, Lleida, Madrid, Majadahonda, Seville, Valencia
2024-07-18
Active, closed
Eli Lilly and Company
Phase 3
10,000
A Coruña, Almería, Alzira, Barcelona, Ferrol, Málaga, Oviedo, Palma de Mallorca
2024-04-30
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Alicante, Córdoba, Ferrol, Madrid, Valencia, Vigo
2024-04-17
Active, closed
Gilead Sciences
Phase 2
228
Ferrol, Huelva, Santa Cruz de Tenerife, Seville, Valencia
2024-03-27
Active, closed
Eli Lilly and Company
Phase 3
17,300
A Coruña, Alcorcón, Badalona, Barcelona, Córdoba, Denia, El Palmar, Murcia, Ferrol
2024-03-05
Recruiting
AbbVie
Phase 3
110
Ferrol, Madrid, Málaga
2023-12-11
Active, closed
AbbVie
Phase 3
122
Ferrol, Esplugues de Llobregat, Barcelona, Málaga
2023-11-06
Active, closed
Eli Lilly and Company
Phase 3
3,127
A Coruña, Ferrol, Almería, Málaga, Seville, Badalona, Barcelona, Valladolid
2023-06-05
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ferrol, Santiago, Santiago Compostela, Elche, Granada, Huelva, Marbella, Málaga
2023-03-09
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Palma de Mallorca, Granollers, L'Hospitalet de Llobregat, Ferrol, Santiago de Compostela, Logroño, Las Palmas de Gran Canaria, Marbella
2022-11-21
Recruiting
Regeneron Pharmaceuticals
Observational
500
Málaga, Sabadell, Jerez de la Frontera, Castellon, Ferrol, Vigo, Almería, Jaén
2022-10-26
Active, closed
Eli Lilly and Company
Phase 3
15,374
A Coruña, Almería, Alzira, Barcelona, Bilbao, Ferrol, Granada, León
2022-10-11
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Barcelona, Ferrol, Girona, Madrid, Majadahonda, Seville, Vigo, Zaragoza
2022-09-27
Recruiting
MicroPort CRM
Observational
206
Ferrol, Majadahonda
2022-03-25
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Ferrol, Madrid, Santander
2022-03-15
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Ferrol, Santiago Compostela, Seville, Mallorca, Palma, el Prat de Llobregat, L'Hospitalet de Llobregat, Sabadell
2021-11-23
Active, closed
University Hospital A Coruña
Observational
82
Ferrol, Santiago de Compostela, Vigo, A Coruña, Lugo, Ourense, Pontevedra
2021-04-20
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Cadiz, Ferrol, Jerez de la Frontera, Madrid, Málaga, Pamplona, Seville, Valencia
2020-11-12
Active, closed
AbbVie
Phase 3
527
Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante
2020-09-30
Active, closed
AbbVie
Phase 3
1,242
Ferrol, Sabadell, Majadahonda, Vigo, Gijón, Barcelona, Córdoba, Madrid
2018-08-28
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Córdoba, Ferrol, Girona, Huelva, Madrid, Oviedo, Pontevedra, Seville
2018-04-13
Active, closed
AbbVie
Phase 3
1,336
Ferrol, L'Hospitalet de Llobregat, Sabadell, Majadahonda, Bilbao, Barcelona, Madrid, Salamanca
2018-04-09
Active, closed
ViiV Healthcare
Phase 3
631
A Coruña, Barcelona, Bilbao, Elche Alicante, Ferrol, Granada, La Laguna Santa Cruz, Madrid
2016-10-27
Recruiting
Thoracic Tumours Register
NCT02941458Thoracic Tumors
Spanish Lung Cancer Group
Observational
10,000
Ferrol, Albacete, Alcoy, Alicante, Elche, Elda, Badalona, Barcelona
2016-07-21
Active, closed
AbbVie
Observational
1,446
A Coruña, Ferrol, Santiago de Compostela, Palma de Mallorca, Badalona, Esplugues de Llobregat, Sabadell, Leganés
2014-08-28
Active, closed
AbbVie
Observational
8,250
A Coruña, Ferrol, Santiago de Compostela, Elche, Sant Joan d'Alacant, Manacor, Palma de Mallorca, Badalona
2013-04-29
Recruiting
Manuel Monreal
Observational
120,000
A Coruña, Cee, Ferrol, Ribeira, Santiago de Compostela, Albacete, Alicante, Elche
2001-03
Rows per page Showing 1–58 of 58
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/ferrol

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 58 of those studies with a site in Ferrol.

How many clinical trials are recruiting in Ferrol?

31 of the 58 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 25 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ferrol), 58 studies
PhaseStudiesRecruitingShare
Phase 3392167.2%
Observational12620.7%
Phase 2426.9%
Not applicable223.4%
Phase 2/3101.7%

Most active sponsors

Lead sponsors with the most studies (Ferrol)
Lead sponsorStudiesRecruiting
Eli Lilly and Company116
AbbVie82
Janssen Research & Development, LLC43
Novo Nordisk A/S43
Hoffmann-La Roche31
AstraZeneca22
Janssen-Cilag Ltd.20
Kailera20
Novartis Pharmaceuticals20
Takeda22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.